Comparing mental health across distinct groups of users of psychedelics, MDMA, psychostimulants, and cannabis

A. ROUGEMONT-BUCKING ; H. JUNGABERLE ; M. SCHEIDEGGER ; M. C. G. MERLO ; V. S. GRAZIOLI ; J. B. DAEPPEN ; G. GMEL ; J. STUDER | 2019
Dans Journal of Psychoactive Drugs (Vol.51, n°3, July-August 2019) Article : Périodique

Differences in mental health (MH) of users of distinct psychoactive substances have been shown. Both substance use (SU) and MH in users are influenced by stressful life events. This study compared MH parameters in distinct groups of substance us[...]

Plus d'info

Ajouter à la sélection

Microdosing psychedelics: Motivations, subjective effects and harm reduction

T. LEA ; N. AMADA ; H. JUNGABERLE ; H. SCHECKE ; M. KLEIN | 2020
Dans International Journal of Drug Policy (Vol.75, January 2020) Article : Périodique

Background: In recent years there has been growing media attention on microdosing psychedelics (e.g., LSD, psilocybin). This refers to people routinely taking small doses of psychedelic substances to improve mental health and wellbeing, or to en[...]

Plus d'info

Ajouter à la sélection

Lien externe